The tariff classification of Guaifenesin and Ephedrine compressed into tablet form, from India
Reasoning
The tariff classification of Guaifenesin and Ephedrine compressed into tablet form, from India
Cite this ruling
CBP Ruling N021984 (3004909176): The tariff classification of Guaifenesin and Ephedrine compressed into tablet form, from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of Pulmozyme® (dornase alfa) Inhalation Solution; Raptiva® (Efalizumab) for injection, subcutaneous; Rituxan® (Rituximab); TNKase™ (Tenecteplase); and Xolair® (Omalizumab) for subcutaneous use
The tariff classification of Pulmozyme® (dornase alfa) Inhalation Solution; Raptiva® (Efalizumab) for injection, subcutaneous; Rituxan® (Rituximab); TNKase™ (Tenecteplase); and Xolair® (Omalizumab) for subcutaneous use
The tariff classification of Activase® (Alteplase recombinant), Avastatin™ (bevacizumab), Cathflo™Activase® (Alteplase) and Herceptin® (Trastuzumab)
The tariff classification of Pulmozyme® (dornase alfa) Inhalation Solution; Raptiva® (Efalizumab) for injection, subcutaneous; Rituxan® (Rituximab); TNKase™ (Tenecteplase); and Xolair® (Omalizumab) for subcutaneous use
The tariff classification of Activase® (Alteplase recombinant), Avastatin™ (bevacizumab), Cathflo™Activase® (Alteplase) and Herceptin® (Trastuzumab)